Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2006;37:2910-2916
Published online before print November 2, 2006, doi: 10.1161/01.STR.0000248768.40043.f9
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/12/2910    most recent
01.STR.0000248768.40043.f9v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmidt, R.
Right arrow Articles by Fazekas, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmidt, R.
Right arrow Articles by Fazekas, F.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Medline Plus Health Information
*Carotid Artery Disease
Related Collections
Right arrow Risk Factors
Right arrow Imaging
Right arrow Brain Circulation and Metabolism
Right arrow Cerebral Lacunes
Right arrow Computerized tomography and Magnetic Resonance Imaging
Right arrow Doppler ultrasound, Transcranial Doppler etc.
Right arrow Risk Factors for Stroke

(Stroke. 2006;37:2910.)
© 2006 American Heart Association, Inc.


Original Contributions

C-Reactive Protein, Carotid Atherosclerosis, and Cerebral Small-Vessel Disease

Results of the Austrian Stroke Prevention Study

Reinhold Schmidt, MD; Helena Schmidt, MD, PhD; Martin Pichler, MD; Christian Enzinger, MD; Katja Petrovic, PhD, MSc; Kurt Niederkorn, MD; Susanna Horner, MD; Stefan Ropele, PhD; Norbert Watzinger, MD; Martin Schumacher, MD; Andrea Berghold, PhD; Gerhard M. Kostner, PhD Franz Fazekas, MD

From the Departments of Neurology (R.S., M.P., C.E., K.P., K.N., S.H., S.R., F.F.) and Radiology (R.S., C.E.); the Institute of Medical Molecular Biology and Medical Biochemistry (H.S., G.M.K.); the Department of Cardiology (N.W., M.S.); and the Institute for Medical Informatics, Statistics and Documentation (A.B.), Medical University of Graz, Graz, Austria.

Correspondence to Reinhold Schmidt, MD, Department of Neurology, Medical University of Graz, Auenbruggerplatz 22, 8036 Graz, Austria. E-mail reinhold.schmidt{at}meduni-graz.at

Background and Purpose— C-reactive protein (CRP) is an inflammatory marker known to be a risk factor for stroke. We examined the associations between CRP, carotid atherosclerosis, white matter lesions, and lacunes as manifestations of cerebral large- and small-vessel disease.

Methods— In the community-based Austrian Stroke Prevention Study, CRP concentrations were measured by a highly sensitive assay in 700 participants at baseline. All underwent carotid duplex scanning, and a subset of 505 subjects underwent brain magnetic resonance imaging. Imaging was repeated after 3 and 6 years. We graded carotid atherosclerosis in both common and internal carotid arteries on a 5-point scale and calculated the sum of scores as an index of the severity of carotid atherosclerosis. The volume of white matter lesions and the number of lacunes were considered small vessel disease–related brain abnormalities.

Results— After adjustment for vascular risk factors, the severity and progression of extracranial carotid atherosclerosis increased with increasing quintiles of CRP. Only study participants in the fourth and fifth quintile (>2.50 mg/L) had significantly more baseline atherosclerosis and greater progression when we used the first quintile (<0.80 mg/L) as a reference. No interactions were seen between CRP quintiles and vascular risk factors for carotid atherosclerosis. The associations between severity and progression of small vessel disease–related brain abnormalities and CRP were nonsignificant.

Conclusions— We found evidence for differential effects of CRP in different beds of the arterial brain supply. CRP was a marker for active carotid atherosclerosis but not for small vessel disease–related brain lesions.


Key Words: carotid atherosclerosis • cerebral small-vessel disease • lacunes • risk factors • white matter lesions




This article has been cited by other articles:


Home page
NeurologyHome page
X. Chen, W. Wen, K. J. Anstey, and P. S. Sachdev
Prevalence, incidence, and risk factors of lacunar infarcts in a community sample
Neurology, July 28, 2009; 73(4): 266 - 272.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
E. Casiglia and V. Tikhonoff
Inflammatory and coagulative markers of atherosclerosis
Eur. Heart J., February 1, 2007; 28(3): 271 - 273.
[Full Text] [PDF]